Alexandria Co. for Pharmaceuticals & Chemical Industries is a leading Egyptian pharmaceutical company that was established in 1962. The company has a diverse range of products, including generic drugs, branded drugs, and other pharmaceuticals. With a commitment to quality and innovation, Alexandria Co. has become a trusted name in the healthcare industry in Egypt and beyond.

Contact Information

Website: www.alexandriapharma.com
Phone: +20 3 427-1600
Email: info@alexandriapharma.com
Address: Alexandria Pharmaceutical Industrial Zone, Abis, Alexandria, Egypt

Other Useful Contact Information:

Investor Relations: ir@alexandriapharma.com
Human Resources: hr@alexandriapharma.com
Media Inquiries: media@alexandriapharma.com
Customer Service: customerservice@alexandriapharma.com

Scientific Offices in Egypt

Alexandria Co. has several scientific offices in Egypt. These offices are located in Cairo, Alexandria, and other major cities. These offices are responsible for conducting research and development activities, providing technical support to customers, and promoting the company’s products.

The scientific offices of Alexandria Co. for Pharmaceuticals & Chemical Industries in Egypt are responsible for conducting research and development activities, providing technical support to customers, and promoting the company’s products. These offices are staffed by a team of scientists, pharmacists, and other healthcare professionals who have expertise in various therapeutic areas.

Some of the scientific offices of Alexandria Co. in Egypt include:

Alexandria Scientific Office: Address: 5 El-Sayadla Towers, El-Asafra, Alexandria, Egypt. Phone: +20 3 480-5002
Cairo Scientific Office: Address: 8A Hassan Sabry St., Zamalek, Cairo, Egypt . Phone: +20 2 2735-0146
Delta Scientific Office: Address: 9 El-Khalifa El-Maamoun St., El-Mansoura, Egypt . Phone: +20 50 223-3404
Upper Egypt Scientific Office: Address: 8 Talaat Harb St., Assiut, Egypt Phone: +20 88 233-3919

In addition to research and development activities, the scientific offices of Alexandria Co. also provide technical support to healthcare professionals, including physicians, pharmacists, and nurses. They provide training on the use of the company’s products, answer technical questions, and provide information on clinical studies and research.

The scientific offices of Alexandria Co. also play an important role in promoting the company’s products. They organize scientific conferences and events, publish scientific papers and articles, and collaborate with healthcare organizations and institutions to raise awareness about the company’s products and services.

Representative Abroad

Alexandria Co. has a strong international presence, with representatives in several countries around the world. The company’s international operations are focused on markets in the Middle East, Africa, and Asia. Some of the countries where Alexandria Co. has representatives include Saudi Arabia, UAE, Yemen, Sudan, Libya, Jordan, Syria, Iraq, Algeria, Tunisia, and Morocco.

Statistics and Company Board

There is limited publicly available information on the statistics and company board of Alexandria Co. for Pharmaceuticals & Chemical Industries. However, the company is listed on the Egyptian Stock Exchange, and its financial performance is publicly reported.

There is no evidence to suggest that Alexandria Co. for Pharmaceuticals & Chemical Industries has been involved in any corruption or unethical practices. The company is committed to operating with the highest standards of integrity and transparency, and it has implemented policies and procedures to prevent corruption and other forms of misconduct.

However, here are some general statistics about the company:

Alexandria Co. for Pharmaceuticals & Chemical Industries is listed on the Egyptian Stock Exchange (EGX) under the ticker symbol ALEX.
The company has a market capitalization of approximately EGP 5.5 billion (as of February 2023).
Alexandria Co. is one of the largest pharmaceutical companies in Egypt and has a strong presence in the Middle East and Africa.
The company has a diversified portfolio of products, including generics, branded drugs, and other pharmaceuticals.
Alexandria Co. has a strong focus on research and development and has invested heavily in developing new products and improving existing ones.
The company has won several awards and recognitions for its contributions to the healthcare industry in Egypt and beyond.

It’s worth noting that these statistics are subject to change and may not be up-to-date. Furthermore, the company may not publicly disclose all of its financial and sales data, so the information available may be limited.

News

Here are some recent news related to the company:

In October 2021, Alexandria Co. announced that it had received approval from the Egyptian Drug Authority (EDA) for the production of a new drug for the treatment of urinary tract infections.
In September 2021, Alexandria Co. announced that it had signed an agreement with the Egyptian Ministry of Health to provide a new vaccine against the coronavirus.
In August 2021, Alexandria Co. reported its financial results for the first half of the year, showing a net profit of EGP 130.9 million, up from EGP 87.9 million in the same period in the previous year.
In July 2021, Alexandria Co. announced that it had signed a memorandum of understanding with the Jordanian pharmaceutical company, Hikma, to collaborate on the development of new drugs.
In June 2021, Alexandria Co. announced that it had signed a distribution agreement with the Algerian pharmaceutical company, Biopharm, to distribute its products in Algeria.
In January 2022, Alexandria Co. announced that it had signed an agreement with the Egyptian Ministry of Health to provide a new drug for the treatment of hepatitis C.
In December 2021, Alexandria Co. announced that it had won the award for the “Best Pharmaceutical Company” at the 2021 Egyptian Health Awards.
In November 2021, Alexandria Co. announced that it had signed a distribution agreement with the Kuwaiti pharmaceutical company, Hikma, to distribute its products in Kuwait.
In October 2021, Alexandria Co. announced that it had signed a memorandum of understanding with the Sudanese pharmaceutical company, Almoj, to collaborate on the development of new drugs.
In August 2021, Alexandria Co. announced that it had signed an agreement with the Egyptian Ministry of Health to provide a new drug for the treatment of cancer.

It’s worth noting that these news and developments may be subject to change and may not represent the most recent updates related to the company.

Alexandria Pharmaceuticals Product Catalog.pdf – Download Link

Product List

شركة الأسكندرية للأدوية والصناعات الكيماوية

Product – AR	Package	Product
الكوفان 100 لبوس	عبوة5 لبوسات	Alcofan 100mg Suppositories
الكوفان 25 مجم أقراص	عبوة 2 شريط- كل شريط 10 أقراص	Alcofan 25mg Tablets
الكوفان 50 مجم كبسول	عبوة شريط 12 كبسولة	Alcofan 50mg Hard Gelatin Capsules
الكوفان جيل موضعى	انبوبة 30 جرام	Alcofan Topical Gel
انتيفير 100 مجم أقراص	عبوة 20 شريط – كل شريط 6 اقراص	Antiver 100mg Tablets
انتيفير شراب معلق	زجاجة 30 مل	Antiver Suspension
باى الكوفان 150 مجم أقراص	عبوة 2 شريط – كل شريط 10 أقراص	Bi-Alcofan 150mg Tablets
بلتراسيد أقراص	عبوة 1 شريط – الشريط 4 أقراص	Biltricide Film Coated Tablets
جليكودال أقراص للمضغ	عبوة 3 شريط – كل شريط 10 أقراص	Glycodal Chewable Tablets
ليدكايين حقن	عبوة 10 امبولات – كل امبولة 2 مل	Lidocaine 2 % Injection
ليدوكايين 2 % حقن	1 فيال 50 مل	Lidocaine 2 % Injection
ليدوكايين 2 % جيل موضعى	انبوبة 20 جرام	Lidocaine 2 % Topical Gel
لوكاستين لبوس مهبلى	عبوة 1 لبوسة	Locasten 1 Vaginal Tablets
لوكاستين 1 % كريم	انبوبة 20 جرام	Locasten 1 % Cream
لوكاستين 1 % محلول	زجاجة 20 مل	Locasten 1 % Solution
لوكاستين 100 مجم لبوس مهبلى – 6 لبوسات	1 شريط 6 أقراص مهبلية	Locasten 100mg Vaginal Tablets
لوكاستين كريم مهبلى	انبوبة 20 جرام + 3 أجهزة للإدراج المهبلى	Locasten 3 Vaginal Cream
ميكلوبرام شراب	زجاجة 120 مل	Meclopram 5mg/5ml Syrup
ميكلوبرام أقراص	عبوة 2 شريط – كل شريط 10 مل	Meclopram 10 mg Tablets
ميكلوبرام حقن	عبوة 5 امبولات – الامبول الواحد 2 مل	Meclopram 10mg/2ml Ampoules
ميكلوبرام نقط الفم	زجاجة 10 مل	Meclopram 2mg/ml Oral Drops
ميكلوبرام 20 مجم لبوس بالغين	شريط واحد بة 5 لبوسات	Meclopram Adult 20 mg Suppositories
ميباكيين إل حقن	عبوة 5 حقنة	Mepecaine – L Cartridges
ميباكيين 3 % حقن	عبوة 50 حقنة	Mepecaine 3% Cartridges
مينوفيللين أقراص	برطمان 30 قرص	Minophylline 300 mg SR Tablets
مينوفيللين لبوس كبار	عبوة 5 لبوسات	Minophylline Adult Suppositories
مينوفيللين لبوس أطفال	عبوة 5 لبوسات	Minophylline Infantile Suppositories
مينوفيللين حقن	عبوة بها 5 امبولات	Minophylline-N 2.5 % Ampoules For I.V. Infusion
ميدرابيد 0.5 % نقط العين	قطارة 10 مل	Mydrapid 0.5% Sterile Eye Drops
ميدرابيد 1 % نقط العين	قطارة 10 مل	Mydrapid 1% Sterile Eye Drops
نصار اقراص	عبوة 12 شريط – كل شريط 8 اقراص	Nassar Tablets
نيو مينوفيللين شراب	زجاجة 120 مل	Neominophylline Syrup
بانادول 500 مجم أقراص	عبوة 2 شريط – كل شريط 12 قرص	Panadol 500 mg Film coated tablets
بانادول إكسترا أقراص	عبوة 2 شريط – الشريط الواحد 12 قرص	Panadol Extra Film coated tablets
بانادول جوينت أقراص	عبوة 2 شريط – الشريط الواحد 18 قرص	Panadol Joint extended release tablets
بيستينون أقراص	عبوة 2 شريط – الشريط 10 أقراص	Pystinon 60 mg Sugar Coated Tablets
سالبوفنت أقراص	عبوة 3 شريط – الشريط 10 أقراص	Salbovent 2mg Tablets
سالبوفنت فورت أقراص	عبوة 2 شريط – الشريط 10 أقراص	Salbovent Forte Tablets
سالبوفنت محلول للحقن	عبوة 5 امبولات	Salbovent Solution for I.M./S.C./I.V. Injection or Infusion
سالبوفنت شراب	زجاجة 120 مل	Salbovent Syrup
سيبتازول فورت أقراص	عبوة 2 شريط – الشريط 10 أقراص	Septazole Forte Tablets
سيبتازول شراب معلق	زجاجة 100 مل	Septazole Oral Suspension
سيبتازول أقراص	عبوة 20 شريط – الشريط 10 اقراص	Septazole Tablets
فيجاسكين مركب لبوس	عبوة 5 لبوسات	Vegaskine Compound Suppositories

Contact Us: If you have any notes or feedback you need to reach us with, feel free contacting us any time via e-mail( Listen2article@gmail.com). Please contact us via email (listen2article@gmail.com) or via contact us form, if the information on this page is incorrect, or if you have other information to update this page.